Jones Michael L 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 2, 2022
Insider Transaction Report
Form 4
Jones Michael L
Exec. Director, Finance - PAO
Transactions
- Exercise/Conversion
Common Stock
2022-12-01$1.42/sh+8,600$12,212→ 19,798 total - Sale
Common Stock
2022-12-01$13.01/sh−8,600$111,886→ 11,198 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2022-12-01−8,600→ 0 totalExercise: $1.42From: 2014-01-01Exp: 2023-01-01→ Common Stock (8,600 underlying)
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $13.01 to $13.03. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.